7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2013-09-30 2012-09-30 
      
                                         
      cash flows from operating activities
                                         
      net income
    181,000,000 128,000,000 -86,000,000 98,000,000 -92,000,000 -1,000,000 -77,000,000 -47,000,000 -382,000,000 27,000,000 -209,000,000 -410,000,000 403,000,000 -139,000,000 -66,000,000 72,000,000 191,000,000 -593,000,000 -607,000,000 -152,000,000 70,000,000 -325,000,000 -152,000,000 -1,517,000,000 -48,000,000 -170,000,000 -48,000,000 -342,000,000 -351,000,000 -760,000,000 -2,691,000,000 512,000,000 1,300,000,000 -37,000,000 629,000,000 -982,841,000 29,252,000 
      adjustments to reconcile net income to net cash from operating activities:
                                         
      depreciation and amortization of intangible assets
    306,000,000 307,000,000 305,000,000 307,000,000 322,000,000 318,000,000 320,000,000 329,000,000 301,000,000 315,000,000 319,000,000 360,000,000 335,000,000 347,000,000 352,000,000 363,000,000 382,000,000 404,000,000 403,000,000 428,000,000 436,000,000 480,000,000 481,000,000 492,000,000 520,000,000 531,000,000 532,000,000 546,000,000 703,000,000 784,000,000 786,000,000 819,000,000 698,000,000 667,000,000 674,000,000   
      amortization and write-off of debt premiums, discounts and issuance costs
    16,000,000 41,000,000 15,000,000  13,000,000 14,000,000 14,000,000  28,000,000 12,000,000 11,000,000  22,000,000 50,000,000 14,000,000  17,000,000 12,000,000 13,000,000  13,000,000 17,000,000 15,000,000  17,000,000 15,000,000 17,000,000           
      asset impairments
       23,000,000 5,000,000 1,000,000  4,000,000 37,000,000 13,000,000          2,000,000 1,000,000 14,000,000 26,000,000 33,000,000 13,000,000 3,000,000 134,000,000 89,000,000 301,000,000 44,000,000 85,000,000 406,000,000 85,000,000 138,000,000   
      acquisition-related contingent consideration
    -32,000,000 -29,000,000 -11,000,000 -5,000,000 25,000,000 -4,000,000 -2,000,000 19,000,000 26,000,000 -17,000,000 31,000,000 27,000,000 4,000,000 -5,000,000 3,000,000 3,000,000   -9,000,000 22,000,000 2,000,000 11,000,000 13,000,000 10,000,000 3,000,000 20,000,000 -21,000,000 14,000,000 -19,000,000 -6,000,000 2,000,000 8,000,000 -238,000,000 -49,000,000 -10,000,000 -38,664,000 -2,099,000 
      allowances for losses on trade receivable and inventories
    12,000,000 10,000,000 26,000,000  11,000,000 17,000,000 15,000,000  11,000,000 22,000,000 10,000,000  17,000,000 5,000,000 14,000,000  16,000,000 18,000,000 17,000,000  18,000,000 19,000,000 15,000,000  19,000,000 14,000,000 13,000,000  15,000,000 16,000,000 17,000,000  23,000,000 24,000,000 24,000,000   
      deferred income taxes
    -24,000,000 -42,000,000 -9,000,000 170,000,000 -3,000,000 -44,000,000 -57,000,000 84,000,000 -3,000,000   19,000,000 -96,000,000 -16,000,000 -83,000,000 -88,000,000 -17,000,000 -106,000,000 -14,000,000 -262,000,000 -19,000,000 -124,000,000 -70,000,000 3,000,000 -92,000,000 -25,000,000 -116,000,000 -142,000,000 40,000,000 -2,000,000 -40,000,000 -1,401,000,000 -1,778,000,000 -253,000,000 -954,000,000 -122,391,000 -101,243,000 
      net gain on sale of assets
         -4,000,000 1,000,000 -5,000,000   -2,000,000    21,000,000 -23,000,000                   
      adjustments to accrued legal settlements
    35,000,000 8,000,000 -3,000,000  188,000,000 21,000,000 6,000,000    1,000,000                          
      payments of accrued legal settlements
    -92,000,000 -87,000,000 -19,000,000 -8,000,000 -218,000,000 -1,000,000 -3,000,000 -7,000,000 -1,000,000 -1,000,000 -1,000,000 -1,212,000,000 -360,000,000 -207,000,000 -15,000,000 -11,000,000 -118,000,000 -86,000,000 -48,000,000 -31,000,000 -3,000,000 -11,000,000 -3,000,000 -1,000,000 -2,000,000 -2,000,000 -50,000,000 -170,000,000 -8,000,000   11,578,000 -35,987,000 
      share-based compensation
    43,000,000 46,000,000 43,000,000 43,000,000 38,000,000 36,000,000 33,000,000 29,000,000 29,000,000 33,000,000 41,000,000 35,000,000 33,000,000 26,000,000 32,000,000 33,000,000 33,000,000 31,000,000 31,000,000 24,000,000 27,000,000 27,000,000 27,000,000 25,000,000 26,000,000 27,000,000 24,000,000 22,000,000 22,000,000 22,000,000 21,000,000 17,000,000 19,000,000 23,000,000 28,000,000 8,619,000 3,391,000 
      gain excluded from hedge effectiveness
    -2,000,000 -3,000,000 -3,000,000 -3,000,000 -4,000,000 -3,000,000 -3,000,000 -3,000,000 -4,000,000 -3,000,000 -3,000,000 -3,000,000    -3,000,000 -6,000,000 -5,000,000 -6,000,000 -6,000,000 -6,000,000                 
      gain on extinguishment of debt
    -3,000,000   -12,000,000 -11,000,000                               
      payments of contingent consideration adjustments, including accretion
    -2,000,000 -2,000,000 -2,000,000 -3,000,000 -2,000,000 -3,000,000 -2,000,000 -6,000,000 -1,000,000   -1,000,000   -8,000,000                  
      amortization of interim contract and inventory step-up resulting from acquisitions
    20,000,000 20,000,000 22,000,000 21,000,000 21,000,000 20,000,000 20,000,000                               
      foreign exchange and other
    5,000,000 -21,000,000 -2,000,000 36,000,000 -15,000,000 -14,000,000 -4,000,000                               
      changes in operating assets and liabilities:
                                         
      trade receivables
    -218,000,000 -91,000,000 110,000,000 -104,000,000 23,000,000 -72,000,000 -63,000,000 -19,000,000 -231,000,000 -53,000,000 108,000,000 -31,000,000 -133,000,000 -90,000,000 197,000,000 -52,000,000 -129,000,000 -108,000,000 60,000,000 103,000,000 -356,000,000 354,000,000 69,000,000 -71,000,000 54,000,000 -33,000,000 89,000,000 160,000,000 -72,000,000 -76,000,000 204,000,000 79,000,000 -114,000,000 20,000,000 432,000,000   
      inventories
    16,000,000 7,000,000 -30,000,000 -49,000,000 -42,000,000 -32,000,000 -144,000,000 -100,000,000 -62,000,000 -32,000,000 -128,000,000 -4,000,000 -56,000,000 -65,000,000 -73,000,000 46,000,000 -15,000,000 -12,000,000 -35,000,000 101,000,000 10,000,000 -94,000,000 -94,000,000 -4,000,000 -84,000,000 -53,000,000 -68,000,000 3,000,000 4,000,000   6,000,000   -38,000,000 -12,190,000 6,646,000 
      prepaid expenses and other current assets
    5,000,000 12,000,000 -46,000,000 13,000,000 1,000,000 -2,000,000 121,000,000 -148,000,000 -21,000,000 -21,000,000 -33,000,000 -34,000,000 16,000,000 -15,000,000 -33,000,000 -41,000,000 16,000,000   1,000,000 27,000,000 2,000,000 -18,000,000 -15,000,000 15,000,000 16,000,000 -15,000,000 -19,000,000 23,000,000 -6,000,000 -70,000,000 1,000,000 12,000,000 18,000,000 2,000,000 44,432,000 -7,457,000 
      accounts payable, accrued and other liabilities
    144,000,000 163,000,000 -99,000,000 24,000,000 144,000,000 138,000,000 51,000,000 97,000,000 166,000,000 -97,000,000 -8,000,000 47,000,000 -96,000,000 49,000,000 -75,000,000 -170,000,000 46,000,000 130,000,000 115,000,000 -185,000,000 70,000,000 -271,000,000 -85,000,000 -116,000,000 26,000,000 -55,000,000 -4,000,000 -228,000,000 84,000,000 -66,000,000 89,000,000 88,000,000 143,000,000 -40,000,000 196,000,000   
      net cash from operating activities
    405,000,000 289,000,000 211,000,000 601,000,000 405,000,000 380,000,000 211,000,000 390,000,000 282,000,000 206,000,000 154,000,000 475,000,000 -1,263,000,000 123,000,000 -63,000,000 24,000,000 564,000,000 395,000,000 443,000,000 394,000,000 256,000,000 200,000,000 261,000,000 234,000,000 515,000,000 339,000,000 413,000,000 319,000,000 522,000,000 222,000,000 438,000,000 578,000,000 490,000,000 268,000,000 954,000,000 -103,316,000 -87,775,000 
      capex
    -91,000,000 -99,000,000 -115,000,000 -106,000,000 -71,000,000 -78,000,000 -82,000,000 -98,000,000 -42,000,000 -28,000,000 -47,000,000 -66,000,000 -54,000,000 -52,000,000 -46,000,000 -78,000,000 -63,000,000 -62,000,000 -66,000,000 -80,000,000 -81,000,000 -69,000,000 -72,000,000 -78,000,000 -83,000,000 -62,000,000 -47,000,000 -62,000,000 -32,000,000 -30,000,000 -33,000,000 -53,000,000 -43,000,000 -37,000,000 -38,000,000 -12,171,000 -43,468,000 
      free cash flows
    314,000,000 190,000,000 96,000,000 495,000,000 334,000,000 302,000,000 129,000,000 292,000,000 240,000,000 178,000,000 107,000,000 409,000,000 -1,317,000,000 71,000,000 -109,000,000 -54,000,000 501,000,000 333,000,000 377,000,000 314,000,000 175,000,000 131,000,000 189,000,000 156,000,000 432,000,000 277,000,000 366,000,000 257,000,000 490,000,000 192,000,000 405,000,000 525,000,000 447,000,000 231,000,000 916,000,000 -115,487,000 -131,243,000 
      cash flows from investing activities
                                         
      acquisitions and other investments
    -5,000,000 -12,000,000 -91,000,000     -1,856,000,000 -31,000,000                           
      purchases of property, plant and equipment
    -91,000,000 -99,000,000 -115,000,000 -106,000,000 -71,000,000 -78,000,000 -82,000,000 -98,000,000 -42,000,000 -28,000,000 -47,000,000 -66,000,000 -54,000,000 -52,000,000 -46,000,000 -78,000,000 -63,000,000 -62,000,000 -66,000,000 -80,000,000 -81,000,000 -69,000,000 -72,000,000 -78,000,000 -83,000,000 -62,000,000 -47,000,000 -62,000,000 -32,000,000 -30,000,000 -33,000,000 -53,000,000 -43,000,000 -37,000,000 -38,000,000 -12,171,000 -43,468,000 
      acquisition of intangible assets and other assets
    -1,000,000 -9,000,000 -1,000,000 -1,000,000 -1,000,000                       -61,000,000 -14,000,000 -19,000,000 -5,000,000 -10,000,000 -131,000,000 27,657,000  
      purchases of marketable securities
    -1,000,000 -1,000,000 -4,000,000 -5,000,000 -2,000,000 -2,000,000 -3,000,000 -14,000,000 -2,000,000 2,000,000 -13,000,000 -2,000,000 -1,000,000 -9,000,000 -5,000,000 -5,000,000 -3,000,000 -6,000,000 -5,000,000 -1,000,000 -1,000,000 -2,000,000 -8,000,000 -3,000,000 -3,000,000 -2,000,000 -2,000,000 -1,000,000   -3,000,000 -3,000,000     
      proceeds from sale of marketable securities
    1,000,000 1,000,000 4,000,000 3,000,000 4,000,000 1,000,000 6,000,000 13,000,000 4,000,000 -2,000,000 11,000,000 2,000,000 7,000,000 7,000,000 6,000,000 4,000,000 3,000,000 6,000,000 2,000,000 1,000,000 1,000,000 4,000,000 2,000,000 7,000,000 2,000,000 1,000,000 2,000,000 1,000,000 2,000,000 2,000,000 1,000,000     
      proceeds from sale of assets and businesses, net of costs to sell
       5,000,000 1,000,000 1,000,000 4,000,000       644,000,000 21,000,000 4,000,000 21,000,000 1,000,000 11,000,000 8,000,000 25,000,000 2,000,000 38,000,000 2,000,000 -8,000,000 190,000,000 919,000,000 827,000,000 1,317,000,000   
      interest settlements from cross-currency swaps
    6,000,000 6,000,000 7,000,000 6,000,000 7,000,000 6,000,000      12,000,000 11,000,000 12,000,000 11,000,000               
      net cash from investing activities
    -83,000,000 -100,000,000 -130,000,000 -200,000,000 -102,000,000 -79,000,000 -73,000,000 -148,000,000 -1,889,000,000 -30,000,000 -78,000,000 -136,000,000 -53,000,000 -58,000,000 -56,000,000 -80,000,000 588,000,000 -43,000,000 -56,000,000 -84,000,000 -70,000,000 -67,000,000 -40,000,000 -85,000,000 -73,000,000 -58,000,000 -203,000,000 -62,000,000 5,000,000 -91,000,000 -48,000,000 90,000,000 869,000,000 780,000,000 1,148,000,000 -3,937,376,000 178,745,000 
      cash flows from financing activities
                                         
      issuance of long-term debt, net of discounts
    -1,000,000 10,372,000,000 50,000,000 506,000,000 80,000,000 75,000,000 146,000,000 2,690,000,000 300,000,000 155,000,000 355,000,000 161,000,000 5,334,000,000 986,000,000 524,000,000 -3,000,000 1,582,000,000 -3,000,000 1,979,000,000 -1,000,000 1,480,000,000 -3,000,000               
      repayments of long-term debt
    -704,000,000 -9,967,000,000 -168,000,000 -411,000,000 -164,000,000 -495,000,000 -390,000,000 -203,000,000 -817,000,000 -411,000,000 -279,000,000 -622,000,000 -141,000,000 -6,598,000,000 -485,000,000 -240,000,000 -1,100,000,000 -1,900,000,000 -200,000,000 -2,480,000,000 -100,000,000 -1,603,000,000 -1,459,000,000 -450,000,000 -453,000,000 -1,882,000,000 -1,621,000,000 -1,901,000,000 -364,000,000 -6,105,000,000 -1,731,000,000 -4,954,000,000 -1,410,000,000 -220,000,000 -7,619,000,000 -4,606,318,000 96,118,000 
      payments of employee withholding taxes related to share-based awards
    -5,000,000 -3,000,000 -16,000,000  -5,000,000 -4,000,000 -14,000,000  -8,000,000 -3,000,000 -12,000,000  -1,000,000 -4,000,000 -25,000,000  -3,000,000 -4,000,000 -41,000,000  -1,000,000 -5,000,000 -24,000,000  -1,000,000 -5,000,000 -34,000,000           
      payments of acquisition-related contingent consideration
    -6,000,000 -5,000,000 -7,000,000 -7,000,000 -8,000,000 -5,000,000 -7,000,000 -18,000,000 -6,000,000 -4,000,000 -7,000,000 -7,000,000 -6,000,000 -5,000,000 -8,000,000 -6,000,000 -36,000,000 -35,000,000 -6,000,000 -5,000,000 -7,000,000 -6,000,000 -17,000,000  -7,000,000 -11,000,000 -9,000,000           
      payments of financing costs
    -2,000,000 -31,000,000 -5,000,000 2,000,000 -3,000,000 -4,000,000 -35,000,000   -37,000,000 -33,000,000 -1,000,000 -10,000,000 -34,000,000 -4,000,000 -21,000,000 -18,000,000 -2,000,000   -40,000,000 -3,000,000 -39,000,000 -20,000,000 -71,000,000 -1,000,000 -38,000,000   
      other
    -1,000,000   -2,000,000    -10,000,000 -7,000,000 10,000,000 -4,000,000 -15,000,000 -6,000,000 10,000,000 -8,000,000 -9,000,000 -6,000,000 -18,000,000 -11,000,000 2,000,000 -2,000,000 -7,000,000 9,000,000 11,000,000 7,000,000 9,000,000 2,000,000 -17,000,000 1,000,000 -3,000,000 -2,000,000 -22,000,000 -1,000,000 -1,000,000 -1,169,000 -5,520,000 
      net cash from financing activities
    -719,000,000 358,000,000 -146,000,000 85,000,000 -189,000,000 -424,000,000 -340,000,000 -79,000,000 1,816,000,000 -120,000,000 -142,000,000 -276,000,000 -36,000,000 -630,000,000 468,000,000 275,000,000 -1,157,000,000 -388,000,000 -243,000,000 -503,000,000 -117,000,000 -153,000,000 -1,521,000,000 2,255,000,000 -474,000,000 -188,000,000 -150,000,000 -502,000,000 -386,000,000 -177,000,000 -288,000,000 -1,842,000,000 -1,430,000,000 -249,000,000 -1,442,000,000 -37,603,000 -300,430,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    -6,000,000 39,000,000 21,000,000                                   
      net increase in cash, cash equivalents and restricted cash
    -403,000,000              341,000,000                       
      cash, cash equivalents and restricted cash, beginning of period
    1,201,000,000            2,119,000,000  1,816,000,000                   
      cash, cash equivalents and restricted cash, end of period
    -403,000,000 586,000,000 1,157,000,000  127,000,000 -132,000,000 755,000,000        2,460,000,000                       
      cash and cash equivalents
    -419,000,000 593,000,000 1,134,000,000  124,000,000 -138,000,000 733,000,000  181,000,000 61,000,000 518,000,000  -173,000,000 -590,000,000 1,249,000,000  48,000,000 -37,000,000 679,000,000  81,000,000 -16,000,000 912,000,000  -53,000,000 96,000,000 782,000,000           
      restricted cash
    16,000,000 -7,000,000 23,000,000  3,000,000 6,000,000 22,000,000  11,000,000 -4,000,000 13,000,000                           
      net decrease in cash, cash equivalents and restricted cash
      -44,000,000                                   
      amortization and write-off of debt discounts and debt issuance costs
                               17,000,000 18,000,000 21,000,000 23,000,000 51,000,000 34,000,000 23,000,000 43,000,000 -5,707,000  
      goodwill impairment
                                 2,213,000,000      
      allowances for losses on trade receivables and inventories
                                         
      additions to accrued legal settlements
                   35,000,000 2,000,000    4,000,000 120,000,000 23,000,000   1,000,000 2,000,000   -1,000,000 11,000,000    76,000,000 148,477,000  
      third party fees paid in connection with the 2022 exchange
                                         
      proceeds from b+l initial public offering, net of costs
                                        
      payment of employee withholding taxes related to share-based awards
                                         
      effect of exchange rate changes on cash and cash equivalents
                  -8,000,000 -4,000,000 -9,000,000 7,000,000 -13,000,000 21,000,000 12,000,000 4,000,000 -21,000,000 13,000,000 -21,000,000 3,000,000 1,000,000 -5,000,000 -6,000,000 -25,000,000 10,000,000 2,000,000 15,000,000 16,000,000 8,000,000 9,598,000 7,137,000 
      net increase in cash, cash equivalents, restricted cash and other settlement deposits
       451,000,000    182,000,000   -60,000,000 94,000,000 -1,382,000,000                         
      cash, cash equivalents, restricted cash and other settlement deposits, beginning of year
                                         
      cash, cash equivalents, restricted cash and other settlement deposits, end of year
                                         
      cash and cash equivalents, end of year
                                         
      restricted cash and other settlement deposits, end of year
                                         
      cash, cash equivalents and restricted cash, end of year
                                         
      goodwill impairments
                119,000,000    469,000,000                   
      effect of exchange rate changes on cash, cash equivalents and other
        13,000,000 -9,000,000 -5,000,000  -17,000,000 1,000,000 6,000,000  -30,000,000                         
      cash, cash equivalents, restricted cash and other settlement deposits, beginning of period
        962,000,000 591,000,000                         
      net (gain) loss on sale of assets
                                         
      net decrease in cash, cash equivalents, restricted cash and other settlement deposits
         -132,000,000 -207,000,000                               
      third party fees paid in connection with the exchange offer
             -3,000,000                          
      asset impairments, including loss on assets held for sale
               1,000,000 6,000,000 8,000,000 21,000,000 18,000,000 47,000,000 148,000,000                   
      acquisition of businesses, net of cash acquired
                           -180,000,000 5,000,000     -3,925,868,000 208,653,000 
      cash, cash equivalents, restricted cash and other settlement deposits, end of period
           182,000,000 192,000,000 57,000,000 531,000,000 94,000,000 -1,382,000,000                         
      foreign exchange gain
              6,000,000             -1,000,000 10,000,000    -1,000,000 10,000,000 -25,000,000  -13,000,000 -39,000,000 -31,000,000  -2,943,000 
      payments for intangible and other assets
            -4,000,000 -3,000,000 -4,000,000  -5,000,000 -4,000,000 -11,000,000  -5,000,000 -2,000,000 -2,000,000  -1,000,000                
      foreign exchange loss
                  -2,000,000 -2,000,000 1,000,000 -5,000,000 12,000,000    16,000,000               
      (gain) loss on extinguishment of debt
               -192,000,000 -570,000,000                         
      foreign exchange (gain) loss
                                         
      restricted cash and other settlement deposits
                -1,209,000,000 9,000,000 1,211,000,000                       
      net proceeds from b+l initial public offering, net of costs
                                         
      cash and cash equivalents, held for sale
                     8,000,000 54,000,000                   
      reductions to accrued legal settlements
                  -1,000,000                       
      loss on extinguishment of debt
                   12,000,000 45,000,000 5,000,000 8,000,000 27,000,000 24,000,000 2,000,000 33,000,000 7,000,000 44,000,000 48,000,000 27,000,000 57,000,000 1,000,000 64,000,000   
      gain on disposal of assets
                                        -795,000 
      settlements from cross-currency swaps
                                         
      borrowings of short-term debt
                                         
      repayments of short-term debt
                          -4,000,000   -2,000,000 -1,000,000 -1,000,000     
      net increase in cash and cash equivalents and restricted cash and other settlement deposits
                                         
      cash and cash equivalents and restricted cash and other settlement deposits, beginning of year
                                         
      cash and cash equivalents and restricted cash and other settlement deposits, end of year
                                         
      proceeds from the issuances of short-term debt
                                       
      net increase in cash, cash equivalents, restricted cash and cash and cash equivalents held for sale
                     -29,000,000 131,000,000                   
      cash, cash equivalents, restricted cash and cash and cash equivalents held for sale, end of period
                     -29,000,000 1,947,000,000                   
      restricted cash, current
                     1,214,000,000  1,011,000,000  2,000,000           
      (gain) loss on disposal of assets
                                         
      additions (reductions) to accrued legal settlements
                           1,389,000,000              
      payments of deferred consideration
                                       
      net increase in cash and cash equivalents and restricted cash
                       -172,000,000 81,000,000 -16,000,000 -1,321,000,000 2,417,000,000 -53,000,000 96,000,000 61,000,000 -250,000,000 135,000,000   -1,172,000,000      
      cash and cash equivalents and restricted cash, beginning of year
                                         
      cash and cash equivalents and restricted cash, end of year
                                         
      restricted cash, end of year
                                         
      gain on sale of assets
                        -1,000,000   1,000,000 -10,000,000           
      cash and cash equivalents and restricted cash, beginning of period
                        3,244,000,000  723,000,000  797,000,000      
      cash and cash equivalents and restricted cash, end of period
                        81,000,000 -16,000,000 1,923,000,000  -53,000,000 96,000,000 784,000,000  135,000,000   -1,172,000,000      
      interest expense on cross-currency swaps
                          -6,000,000               
      (gain) loss on disposal of assets and businesses
                                         
      insurance proceeds for legal settlement
                                   40,000,000     
      payment of share-based awards tax withholding
                                         
      payments of contingent consideration
                               -11,000,000 -8,000,000 -7,000,000 -11,000,000 -11,000,000 -9,000,000 -17,000,000 -8,000,000 46,755,000 14,692,000 
      (gain) loss on sale of assets
                                         
      net proceeds from the issuances of long-term debt
                            -5,000,000 1,729,000,000 1,514,000,000           
      debt extinguishment costs
                              -1,000,000           
      acquisition accounting adjustment on inventory sold
                                       122,882,000 -4,285,000 
      gain on disposal of assets and businesses
                                         
      (reductions) additions to accrued legal settlements
                               3,000,000          
      reduction of cash due to deconsolidation
                                         
      proceeds from exercise of stock options
                               1,000,000        644,000 3,298,000 
      payment of employee withholding tax upon vesting of share-based awards
                                 -3,000,000 -5,000,000 -1,000,000     
      gain on disposals of assets and businesses
                                    -328,000,000     
      issuances of long-term debt, net of discount
                                         
      payments of employee withholding tax upon vesting of share-based awards
                                       296,000 2,534,000 
      restricted cash, noncurrent
                                         
      payment of contingent consideration adjustments, including accretion
                                    -1,000,000 -1,000,000 -1,000,000   
      issuance of long-term debt, net of discount
                                 5,993,000,000 1,481,000,000 3,193,000,000 -1,000,000 -2,000,000 6,234,000,000 6,825,121,000 -518,472,000 
      cash and cash equivalents, end of period
                                 -71,000,000 909,000,000 -244,000,000 -250,000,000 4,000,000 1,210,000,000 -1,943,043,000 -137,536,000 
      restricted cash, end of period
                                   -851,000,000      
      net increase in cash and cash equivalents
                                  112,000,000    668,000,000 -4,068,697,000 -202,323,000 
      net settlement of assumed derivative contracts
                                         
      repayments of convertible notes assumed
                                         
      issuance of common stock
                                       -2,272,620,000  
      repurchases of common shares
                                         
      loss on deconsolidation
                                         
      restricted cash included in other non-current assets, end of period
                                         
      additions (reduction) to accrued legal settlements
                                         
      restricted cash included in current assets, end of period
                                         
      (gain) loss on disposals of assets and businesses
                                      -317,000,000   
      short-term debt borrowings
                                       -9,407,000 -3,306,000 
      short-term debt repayments
                                      -1,000,000 -14,403,000 16,762,000 
      tax benefit from share-based compensation
                                         
      acquisition of noncontrolling interest
                                      -9,000,000   
      cash and cash equivalents, beginning of period
                                      542,000,000 2,125,654,000 64,787,000 
      depreciation and amortization, including impairments of finite-lived intangible assets
                                         
      in-process research and development impairments
                                         
      allowances for losses on accounts receivable and inventories
                                       4,544,000 5,113,000 
      deferred income tax (benefit) expense
                                         
      proceeds from sales and maturities of short-term investments
                                         
      settlement of foreign currency forward exchange contracts
                                         
      increase in restricted cash and cash equivalents
                                         
      non-cash investing and financing activities
                                         
      acquisition of businesses, contingent and deferred consideration obligations at fair value
                                         
      acquisition of businesses, debt assumed
                                       -4,217,113,000  
      in-process research and development impairments and other charges
                                       119,151,000  
      loss on disposal of assets
                                         
      tax benefits from stock options exercised
                                       -20,334,000 515,000 
      gain on sale of marketable securities
                                         
      payment of accreted interest on contingent consideration
                                       -1,113,000 346,000 
      accounts receivable
                                       97,736,000 -190,829,000 
      accounts payable, accrued liabilities and other liabilities
                                       -101,233,000 93,387,000 
      proceeds from sales and maturities of marketable securities
                                         
      purchases of marketable securities and other investments
                                         
      proceeds from sale of assets
                                         
      increase in restricted cash
                                         
      repurchases of convertible debt
                                         
      cash settlement of convertible debt
                                         
      distributions to noncontrolling interest
                                         
      payments of debt issuance costs
                                       -46,528,000 -21,455,000 
      acquisition of businesses, contingent consideration obligations at fair value
                                         
      depreciation and amortization
                                        13,445,000 
      (gain) loss on sale of marketable securities
                                         
      amortization of debt discounts and debt issuance costs
                                        9,370,000 
      acquired in-process research and development
                                        140,732,000 
      income taxes payable
                                        14,810,000 
      acquisition of intangible assets
                                        -5,610,000 
      decrease (increase) in restricted cash
                                         
      cash settlement of call options
                                         
      acquisition of businesses, contingent consideration at fair value
                                        91,027,000 
      settlement of convertible debt, equity issued
                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.